INVESTMENT MANAGEMENT OF VIRGINIA LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 182 filers reported holding HAEMONETICS CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
INVESTMENT MANAGEMENT OF VIRGINIA LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2018$1,650,000
-35.3%
22,542
-48.7%
0.19%
-36.6%
Q4 2017$2,552,000
+134.3%
43,942
+81.0%
0.30%
+18.4%
Q3 2017$1,089,000
+11.3%
24,275
-2.0%
0.26%
+8.9%
Q2 2017$978,000
-4.9%
24,778
-2.2%
0.24%
-7.1%
Q1 2017$1,028,000
+0.2%
25,337
-0.8%
0.25%
+3.3%
Q4 2016$1,026,000
+4.8%
25,534
-5.6%
0.24%
+2.1%
Q3 2016$979,00027,0370.24%
Other shareholders
HAEMONETICS CORP shareholders Q1 2017
NameSharesValueWeighting ↓
AMERICAN CAPITAL MANAGEMENT INC 736,870$31,044,0003.85%
Black Creek Investment Management Inc. 555,577$23,406,0002.75%
SNYDER CAPITAL MANAGEMENT L P 1,294,884$54,553,0002.68%
KESTREL INVESTMENT MANAGEMENT CORP 452,400$19,060,0002.34%
Van Berkom & Associates Inc. 907,795$38,245,0002.14%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 2,059,363$86,761,0001.45%
Champlain Investment Partners, LLC 1,288,230$54,273,0000.96%
HERMES INVESTMENT MANAGEMENT LTD 734,973$30,964,0000.94%
Netols Asset Management, Inc. 146,621$6,177,0000.94%
ANCHOR CAPITAL ADVISORS LLC 1,112,360$46,864,0000.93%
View complete list of HAEMONETICS CORP shareholders